Singular Wings Medical is proud to announce that the company has obtained a new patent in Japan, marking a significant milestone in the advancement of our non-invasive health monitoring technologies.
The patent — “Methods and Computing Devices for Non-Invasive Blood Glucose Estimation, Devices for Non-Invasive ECG Signal Measurement, and Non-Transitory Computer-Readable Recording Media” (Application No. 2024-226742) — recognizes our achievements in next-generation sensing and algorithm innovation.
This patented technology strengthens our capabilities in non-invasive blood glucose estimation and non-invasive ECG acquisition, providing accurate physiological insights without the discomfort of traditional methods.
The obtainment of this patent further reinforces Singular Wings Medical’s global innovation strategy and our commitment to shaping the future of preventive healthcare.
